Tag Archives: peritoneal carcinomatosis

Colorectal Cancer News in Brief: June 12

Briefs are back this week after a couple of weeks off for the ASCO meeting, and we review research that finds small liver mets don’t affect survival after treatment for peritoneal carcinomatosis.  A gene has been found  that’s necessary for Celebrex to control new colon polyps. In other headlines, chimps don’t get cancer but aren’t as smart as humans, a new clinical trial is underway for people with KRAS mutant tumors, and a subcommittee of the House Veterans Affairs Committee will be holding hearings to investigate infections from poorly sanitized colonoscopes in VA medical centers. Two helpful publications are available online:  One provides help understanding medical abstracts; the other is

Surgery with HIPEC Increases Long Term Survival for Peritoneal Carcinomatosis

Over half of patients whose colorectal cancer had spread to their abdominal cavity were alive five years after treatment in a French center with surgery and heated chemo.  This was substantially better than those who only received modern chemotherapies without surgery. Peritoneal carcinomatosis is diagnosed when cancer spreads into the abdominal cavity and tumors develop on the surface of abdominal organs.  In the past peritoneal carcinomatosis has been a difficult condition to treat with very poor results from chemotherapy.  However, surgery to remove all signs of tumor followed by washing the open abdomen after surgery with heated chemotherapy is achieving some remarkable results.